2004年1月
Lactoferrin enhances peripheral opioid-mediated antinociception via nitric oxide in rats
EUROPEAN JOURNAL OF PHARMACOLOGY
- ,
- ,
- 巻
- 484
- 号
- 2-3
- 開始ページ
- 175
- 終了ページ
- 181
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.ejphar.2003.11.007
- 出版者・発行元
- ELSEVIER SCIENCE BV
Lactoferrin (LF) is a multifunctional protein found in various biological fluids. However, the peripheral action of lactoferrin remains unknown. In this study, peripherally applied bovine lactoferrin showed antinociceptive effect that was reversed by a mu-opioid, receptor antagonist, D-Phe-Cys-Tyr-D-Tip-Orn-Thr-NH2 (CTOP), or by a nitric oxide synthase (NOS) inhibitor, N-G-nitro-L-arginine methyl ester (L-NAME), but not by an inactive enantiomer of L-NAME, N-G-nitro-D-arginine methyl ester (D-NAME), during phase 1 and phase 2 in the rat formalin test. Peripheral coadministration of a mu-opioid receptor agonist, morphine, with subeffective dose of bovine lactoferrin produced a potentiated antinociceptive effect compared to that of morphine alone during both phases in the formalin test. This potentiated antinociception by morphine with bovine lactoferrin was reversed by CTOP or by L-NAME. These results suggest that bovine lactoferrin exerts an antinociceptive activity via potentiation of the peripheral mu-opioidergic system, and that nitric oxide (NO) is involved in this potentiation. (C) 2003 Elsevier B.V All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.ejphar.2003.11.007
- ISSN : 0014-2999
- Web of Science ID : WOS:000188610800007